Keystone Heart to Accelerate Trials for a New Advanced Cerebral Embolic Protection Device Post author:Sam Post published:August 1, 2017 Post category:BioPharma Life Sciences Jobs … Source: BioSpace You Might Also Like Esperion's Cholesterol Drug Positive in PhIII Trial March 6, 2018 Up-and-Coming Chinese Biotech BeiGene Gets $750M Worth of Love From U.S. Investors January 18, 2018 AbbVie Declares Quarterly Dividend February 19, 2017